newsfilter
← Latest News
GlobeNewswire·

CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

- All sites activated with 38 patients dosed in the potentially pivotal Phase 2 clinical study, FIRCE-1 of firicabtagene autoleucel (firi-cel) - - Completed $110 million private placement equity financing, extending